GAMMA Investing’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$436K Buy
2,269
+325
+17% +$52.9K 0.01% 776
2026
Q2
$265K Buy
1,944
+433
+29% +$53.2K 0.01% 1054
2026
Q1
$178K Buy
1,511
+417
+38% +$58.3K 0.01% 1210
2025
Q4
$179K Buy
1,094
+296
+37% +$46.4K 0.01% 1118
2025
Q3
$107K Sell
798
-28
-3% -$3.4K 0.01% 1461
2025
Q2
$103K Sell
826
-132
-14% -$16.8K 0.01% 1419
2025
Q1
$122K Buy
958
+274
+40% +$42.2K 0.01% 1095
2024
Q4
$98.5K Buy
684
+90
+15% +$12.9K 0.01% 1128
2024
Q3
$88.4K Buy
594
+115
+24% +$16.5K 0.01% 1081
2024
Q2
$60.4K Buy
479
+310
+183% +$48.6K 0.01% 1063
2024
Q1
$31.1K Buy
169
+51
+43% +$9.71K 0.01% 1342
2023
Q4
$22.3K Buy
+118
New +$18.4K 0.01% 1422

Other funds holding RGEN

GAMMA Investing's RGEN Position: Q3 2026 in Review

GAMMA Investing increased its Repligen (RGEN) stake by 17% in Q3 2026, buying an estimated $52.9K and bringing the position to 2,269 shares worth $436K. The position accounts for 0.01% of the portfolio, ranked #776.

GAMMA Investing first reported a position in RGEN in Q4 2023 and has held it in 12 quarters since. 16 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • GAMMA Investing held 2,269 shares of Repligen worth $436K as of Q3 2026.
  • GAMMA Investing bought 325 Repligen shares in Q3 2026, an estimated $52.9K.
  • Repligen made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #776 holding.
  • GAMMA Investing first reported a position in Repligen in Q4 2023 and has held it in 12 quarters since.
  • 16 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.